


BioWin expands its ‘Growth & Financing’ member service by appointing two industry experts

EverImmune appoints Prof. Laurence Zitvogel as president of scientific advisory board

Enalees opens first subsidiary in the UK

Oncovita presents preclinical data on its promising MVdeltaC oncolytic vaccine at SITC Annual Meeting 2022

Alderaan Biotechnology presents latest developments in next generation anti-CD25 antibody at SITC Congress

Positive results from AELIX’ HIV therapeutic vaccine clinical study published in Nature Medicine

Enalees receives €500,000 subsidy

ABL and Imugene partner to advance oncolytic virus candidate towards later phase clinical trials
